• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人抗水痘免疫球蛋白在预防水痘中的应用。

Human anti-chickenpox immunoglobulin in the prevention of chickenpox.

作者信息

Evans E B, Pollock T M, Cradock-Watson J E, Ridehalgh M K

出版信息

Lancet. 1980 Feb 16;1(8164):354-6. doi: 10.1016/s0140-6736(80)90897-1.

DOI:10.1016/s0140-6736(80)90897-1
PMID:6101802
Abstract

Human anti-chickenpox immunoglobulin (zoster immune globulin, ZIG) was largely ineffective in preventing infection in forty-three high-risk contacts of chickenpox. Twenty-nine of these non-immune infants and children who had been in close contact with cases of varicella became infected, and symptoms developed in twenty-four. Since ZIG may modify chickenpox it should continue to be given to high-risk contacts until the availability of a simple and sensitive test makes it possible to identify those who are susceptible. However, ZIG is not necesary for infants whose mothers have chickenpox or zoster five or more days before delivery, since all such infants (eleven) had varicella-zoster antibody at birth.

摘要

人抗水痘免疫球蛋白(带状疱疹免疫球蛋白,ZIG)在预防43例水痘高危接触者感染方面基本无效。这些与水痘患者密切接触的29名非免疫婴幼儿被感染,其中24人出现症状。由于ZIG可能改变水痘病情,在有简单灵敏的检测方法能够识别易感者之前,仍应继续给予高危接触者ZIG。然而,对于母亲在分娩前5天或更早患水痘或带状疱疹的婴儿,ZIG并非必需,因为所有此类婴儿(11名)出生时均有水痘-带状疱疹抗体。

相似文献

1
Human anti-chickenpox immunoglobulin in the prevention of chickenpox.人抗水痘免疫球蛋白在预防水痘中的应用。
Lancet. 1980 Feb 16;1(8164):354-6. doi: 10.1016/s0140-6736(80)90897-1.
2
Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.围产期母亲感染水痘-带状疱疹病毒后给予新生儿抗水痘-带状疱疹免疫球蛋白的结局
Lancet. 1989 Aug 12;2(8659):371-3. doi: 10.1016/s0140-6736(89)90547-3.
3
Effect of zoster immunoglobulin for varicella prophylaxis in the newborn.
Scand J Infect Dis. 1985;17(4):343-7. doi: 10.3109/13813458509058773.
4
Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.使用标准化水痘-带状疱疹酶联免疫吸附测定试验对妊娠期水痘-带状疱疹接触者和感染者进行管理。
Postgrad Med J. 1985;61 Suppl 4:23-30.
5
Zoster immunoglobulin in varicella prophylaxis. A study among high-risk patients.
Scand J Infect Dis. 1983;15(4):327-34. doi: 10.3109/inf.1983.15.issue-4.02.
6
Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.水痘、潜伏期及带状疱疹期间的水痘-带状疱疹免疫球蛋白
J Infect Dis. 1975 Jul;132(1):49-54. doi: 10.1093/infdis/132.1.49.
7
Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.水痘的预防:免疫实践咨询委员会(ACIP)的建议。疾病控制与预防中心。
MMWR Recomm Rep. 1996 Jul 12;45(RR-11):1-36.
8
[Management of varicella-zoster virus infections. No systematic vaccination against varicella in France].[水痘-带状疱疹病毒感染的管理。法国未开展针对水痘的系统性疫苗接种]
Presse Med. 1998;27(24):1237.
9
[Diaplacental transmission of varicella zoster virus antibodies after chickenpox at the time of birth].出生时患水痘后水痘带状疱疹病毒抗体的胎盘传播
Geburtshilfe Frauenheilkd. 1993 Feb;53(2):105-7. doi: 10.1055/s-2007-1023646.
10
[Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].[水痘-带状疱疹病毒感染。1:水痘和带状疱疹。治疗与预防]
MMW Fortschr Med. 2006;Spec no.1:1-5; quiz 6.

引用本文的文献

1
Management of varicella in neonates and infants.新生儿和婴儿水痘的管理。
BMJ Paediatr Open. 2019 May 30;3(1):e000433. doi: 10.1136/bmjpo-2019-000433. eCollection 2019.
2
Updated recommendations for use of VariZIG--United States, 2013.更新的 VariZIG 使用建议——美国,2013 年。
MMWR Morb Mortal Wkly Rep. 2013 Jul 19;62(28):574-6.
3
An analysis of infection control of varicella-zoster virus infections in Addenbrooke's Hospital Cambridge over a 5-year period, 1987-92.1987年至1992年期间,对剑桥阿登布鲁克医院水痘-带状疱疹病毒感染的感染控制情况进行的分析。
Epidemiol Infect. 1996 Aug;117(1):165-71. doi: 10.1017/s0950268800001278.
4
Clinical pharmacology: plasma protein binding of drugs.临床药理学:药物的血浆蛋白结合
Br Med J (Clin Res Ed). 1981 Jan 17;282(6259):212-4. doi: 10.1136/bmj.282.6259.212.
5
Intravenous gammaglobulin for immunodeficiency: report from The European Group for Immunodeficiencies (EGID).静脉注射免疫球蛋白治疗免疫缺陷:欧洲免疫缺陷小组(EGID)报告
Clin Exp Immunol. 1986 Sep;65(3):683-90.